FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161176275> ?p ?o ?g. }

• W2161176275 endingPage "202" @default.
• W2161176275 startingPage "195" @default.
• W2161176275 abstract "Abstract Ethyl 2-((2,3-bis(nitrooxy)propyl)disulfanyl)benzoate (GT-094) is a novel nitric oxide (NO) chimera containing an nonsteroidal anti-inflammatory drug (NSAID) and NO moieties and also a disulfide pharmacophore that in itself exhibits cancer chemopreventive activity. In this study, the effects and mechanism of action of GT-094 were investigated in RKO and SW480 colon cancer cells. GT-094 inhibited cell proliferation and induced apoptosis in both cell lines and this was accompanied by decreased mitochondrial membrane potential (MMP) and induction of reactive oxygen species (ROS), and these responses were reversed after cotreatment with the antioxidant glutathione. GT-094 also downregulated genes associated with cell growth [cyclin D1, hepatocyte growth factor receptor (c-Met), epidermal growth factor receptor (EGFR)], survival (bcl-2, survivin), and angiogenesis [VEGF and its receptors (VEGFR1 and VEGFR2)]. Results of previous RNA interference studies in this laboratory has shown that these genes are regulated, in part, by specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4 that are overexpressed in colon and other cancer cell lines and not surprisingly, GT-094 also decreased Sp1, Sp3, and Sp4 in colon cancer cells. GT-094–mediated repression of Sp and Sp-regulated gene products was due to downregulation of microRNA-27a (miR-27a) and induction of ZBTB10, an Sp repressor that is regulated by miR-27a in colon cancer cells. Moreover, the effects of GT-094 on Sp1, Sp3, Sp4, miR-27a, and ZBTB10 were also inhibited by glutathione suggesting that the anticancer activity of GT-094 in colon cancer cells is due, in part, to activation of an ROS-miR-27a:ZBTB10-Sp transcription factor pathway. Mol Cancer Res; 9(2); 195–205. ©2010 AACR." @default.
• W2161176275 created "2016-06-24" @default.
• W2161176275 creator A5020757036 @default.
• W2161176275 creator A5036119110 @default.
• W2161176275 creator A5036575223 @default.
• W2161176275 creator A5045907629 @default.
• W2161176275 creator A5050083954 @default.
• W2161176275 creator A5070221783 @default.
• W2161176275 creator A5090885184 @default.
• W2161176275 date "2011-02-01" @default.
• W2161176275 modified "2023-09-27" @default.
• W2161176275 title "GT-094, a NO-NSAID, Inhibits Colon Cancer Cell Growth by Activation of a Reactive Oxygen Species-MicroRNA-27a: ZBTB10-Specificity Protein Pathway" @default.
• W2161176275 cites W1526269920 @default.
• W2161176275 cites W1554678066 @default.
• W2161176275 cites W1969499993 @default.
• W2161176275 cites W1975076018 @default.
• W2161176275 cites W1980952563 @default.
• W2161176275 cites W1982248155 @default.
• W2161176275 cites W1996272511 @default.
• W2161176275 cites W2008644469 @default.
• W2161176275 cites W2016403221 @default.
• W2161176275 cites W2019204684 @default.
• W2161176275 cites W2023695651 @default.
• W2161176275 cites W2024885145 @default.
• W2161176275 cites W2033527062 @default.
• W2161176275 cites W2040603499 @default.
• W2161176275 cites W2061981941 @default.
• W2161176275 cites W2063675387 @default.
• W2161176275 cites W2068978328 @default.
• W2161176275 cites W2070412642 @default.
• W2161176275 cites W2086545536 @default.
• W2161176275 cites W2088312168 @default.
• W2161176275 cites W2096303392 @default.
• W2161176275 cites W2097903769 @default.
• W2161176275 cites W2107534719 @default.
• W2161176275 cites W2111366648 @default.
• W2161176275 cites W2114120215 @default.
• W2161176275 cites W2121348098 @default.
• W2161176275 cites W2126356018 @default.
• W2161176275 cites W2126469731 @default.
• W2161176275 cites W2126762394 @default.
• W2161176275 cites W2126830043 @default.
• W2161176275 cites W2126894693 @default.
• W2161176275 cites W2128753121 @default.
• W2161176275 cites W2134234269 @default.
• W2161176275 cites W2136752130 @default.
• W2161176275 cites W2137820569 @default.
• W2161176275 cites W2141999680 @default.
• W2161176275 cites W2147339810 @default.
• W2161176275 cites W2151324279 @default.
• W2161176275 cites W2160901667 @default.
• W2161176275 cites W2166797557 @default.
• W2161176275 cites W2167342060 @default.
• W2161176275 cites W2170241782 @default.
• W2161176275 doi "https://doi.org/10.1158/1541-7786.mcr-10-0363" @default.
• W2161176275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3069691" @default.
• W2161176275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21156786" @default.
• W2161176275 hasPublicationYear "2011" @default.
• W2161176275 type Work @default.
• W2161176275 sameAs 2161176275 @default.
• W2161176275 citedByCount "105" @default.
• W2161176275 countsByYear W21611762752012 @default.
• W2161176275 countsByYear W21611762752013 @default.
• W2161176275 countsByYear W21611762752014 @default.
• W2161176275 countsByYear W21611762752015 @default.
• W2161176275 countsByYear W21611762752016 @default.
• W2161176275 countsByYear W21611762752017 @default.
• W2161176275 countsByYear W21611762752018 @default.
• W2161176275 countsByYear W21611762752019 @default.
• W2161176275 countsByYear W21611762752020 @default.
• W2161176275 countsByYear W21611762752021 @default.
• W2161176275 countsByYear W21611762752022 @default.
• W2161176275 countsByYear W21611762752023 @default.
• W2161176275 crossrefType "journal-article" @default.
• W2161176275 hasAuthorship W2161176275A5020757036 @default.
• W2161176275 hasAuthorship W2161176275A5036119110 @default.
• W2161176275 hasAuthorship W2161176275A5036575223 @default.
• W2161176275 hasAuthorship W2161176275A5045907629 @default.
• W2161176275 hasAuthorship W2161176275A5050083954 @default.
• W2161176275 hasAuthorship W2161176275A5070221783 @default.
• W2161176275 hasAuthorship W2161176275A5090885184 @default.
• W2161176275 hasBestOaLocation W21611762751 @default.
• W2161176275 hasConcept C104317684 @default.
• W2161176275 hasConcept C127561419 @default.
• W2161176275 hasConcept C153911025 @default.
• W2161176275 hasConcept C185592680 @default.
• W2161176275 hasConcept C190283241 @default.
• W2161176275 hasConcept C2775975398 @default.
• W2161176275 hasConcept C48349386 @default.
• W2161176275 hasConcept C502942594 @default.
• W2161176275 hasConcept C55493867 @default.
• W2161176275 hasConcept C62112901 @default.
• W2161176275 hasConcept C86803240 @default.
• W2161176275 hasConcept C95444343 @default.
• W2161176275 hasConceptScore W2161176275C104317684 @default.
• W2161176275 hasConceptScore W2161176275C127561419 @default.
• W2161176275 hasConceptScore W2161176275C153911025 @default.
• W2161176275 hasConceptScore W2161176275C185592680 @default.

• next